Science Explorer Back to mapMap
Discussion
Researcher · Chitkara University · India

Ankush Kumar

Ankush Kumar publishes mostly in Molecular Biology, Organic Chemistry and Oncology, on topics such as Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors and Synthesis and biological activity.

ORCID 0009-0006-5798-4719 OpenAlex
World rank
#3,013,290
of 7,710,434 ranked researchers
Rank in India
#61,864
of 280,097
Works
36
Citations
160
Citations per work
4.4
h-index
7
i10-index 5Top 91% in Molecular Biology
Ankush Kumar

What does Ankush Kumar research?

Ankush Kumar's work is mostly in Biochemistry, Genetics and Molecular Biology (16%), Chemistry (12%), Medicine (8%).

Everything else: 18 works · 51.3% of their workPhysical Sciences: 7 works · 20.5% of their workChemistry: 4 works · 11.7% of their workOrganic Chemistry: 4 works · 11.7% of their workEngineering: 2 works · 4.9% of their workBiomedical Engineering: 2 works · 4.9% of their workEnvironmental Science: 1 works · 3.9% of their workEnvironmental Engineering: 1 works · 3.9% of their workLife Sciences: 7 works · 20.4% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 15.5% of their workMolecular Biology: 6 works · 15.5% of their workAgricultural and Biological Sciences: 2 works · 4.9% of their workPlant Science: 2 works · 4.9% of their workHealth Sciences: 3 works · 7.8% of their workMedicine: 3 works · 7.8% of their workOncology: 3 works · 7.8% of their workTHEIR WORKAnkush Kumar36works
Life Sciences20%Physical Sciences21%Health Sciences8%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1851.3%
    1. Chemistry411.7%
    2. Engineering24.9%
    3. Environmental Science13.9%
    1. Biochemistry, Genetics and Molecular Biology615.5%
    2. Agricultural and Biological Sciences24.9%
    1. Medicine37.8%
  1. 1Molecular Biology16% of their works
  2. 2Organic Chemistry12% of their works
  3. 3Oncology8% of their works
  4. 4Biomedical Engineering5% of their works
  5. 5Plant Science5% of their works
  6. 6Environmental Engineering4% of their works

Research topics

Which keywords describe Ankush Kumar's research?

The keywords of their largest research topics: Cancer Therapy, BET Bromodomains, Breast Cancer, HDAC Inhibitors, HER2, Heterocyclic Compounds, Histone Deacetylases and Medicinal Chemistry.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Cancer Therapy52 topics
  2. BET Bromodomains31 topic
  3. Breast Cancer31 topic
  4. HDAC Inhibitors31 topic
  5. HER231 topic
  6. Heterocyclic Compounds31 topic
  7. Histone Deacetylases31 topic
  8. Medicinal Chemistry31 topic
  9. PROTACs31 topic
  10. BRAF gene21 topic
  11. Biomedical Applications21 topic
  12. Click Chemistry21 topic
  13. Copper-Catalyzed Cycloaddition21 topic
  14. Crohn's Disease21 topic
  15. Hydrogels21 topic
  16. Inflammatory Bowel Disease21 topic
  17. MAP Kinase21 topic

Where does Ankush Kumar work?

Ankush Kumar's main affiliation in the publication record is Chitkara University, India.

How many publications and citations does Ankush Kumar have?

OpenAlex counts 36 works and 160 citations for Ankush Kumar, an h-index of 7, ranking #3,013,290 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Ankush Kumar

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ankush Kumar. Posts are plain text and can be reported.